Monistat Tioconazole 1 Ointment
NDC Package 63736-413-01
Package Information
Monistat Tioconazole 1 (tioconazole) ointment is before using this product read the enclosed brochure and instructions on foil packet for complete directions and informationadults and children 12 years of age and over:○ open the foil packet just before use and remove purple cap○ insert entire content of applicator into the vagina at bedtime. This formulation utilizes a ointment delivery system. Marketed by Insight Pharmaceuticals Llc, this product is identified by NDC 63736-413 and is authorized under FDA application ANDA075915.
Identification & Billing
- RxCUI: 1661176 - Monistat Simple Therapy 6.5 % Vaginal Ointment
- RxCUI: 1661176 - tioconazole 0.065 MG/MG Vaginal Ointment [Monistat Simple Therapy]
- RxCUI: 198380 - tioconazole 6.5 % Vaginal Ointment
- RxCUI: 198380 - tioconazole 0.065 MG/MG Vaginal Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63736 - Insight Pharmaceuticals Llc
- 63736-413 - Monistat Tioconazole 1
- 63736-413-01 - 1 APPLICATOR in 1 CARTON / 4.6 g in 1 APPLICATOR
- 63736-413 - Monistat Tioconazole 1
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63736-413-01 identifies a specific commercial package of 1 applicator in 1 carton / 4.6 g in 1 applicator of Monistat Tioconazole 1, a human over the counter drug labeled by Insight Pharmaceuticals Llc. This ointment is formulated for topical use and contains tioconazole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Insight Pharmaceuticals Llc on November 21, 2001. The current certification is valid through December 31, 2026.
How is this Insight Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63736041301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.